Zim Laboratories has informed that the meeting of the Board of Directors of the Company is scheduled on 19/05/2023 to consider and approve the Audited Financial Statements (Standalone and Consolidated) of the Company for the year ended 31st March, 2023; consider and approve the Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended 31st March, 2023 (prepared pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015). In connection with the above, as per SEBI (Prohibition of Insider Trading) Regulation, 2015 and Company's Code of Conduct to Regulate, Monitor and Report of Trading by Insiders, the trading window for dealing with securities of the Company is closed from Saturday 01st April, 2023 to Sunday the 21st May, 2023.
The above information is a part of company’s filings submitted to BSE.
